Allarity Therapeutics Inc (NAS:ALLR) Stock News, Headlines & Updates
Allarity Therapeutics Inc Stock News from GuruFocus
- 1
Jul 15, 2025
Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization
Marketwired • 7:00am
Jul 07, 2025
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer | ALLR Stock News
GuruFocus News • 7:20am
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer
Marketwired • 7:00am
Jun 30, 2025
Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic
Marketwired • 7:00am
Jun 27, 2025
Allarity (ALLR) Advances Stenoparib Clinical Trial for Ovarian Cancer | ALLR Stock News
GuruFocus News • 7:31am
Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer | ALLR Stock News
GuruFocus News • 7:17am
Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer
Marketwired • 7:00am
Jun 11, 2025
Allarity Therapeutics Announces Changes to Board of Directors
Marketwired • 4:00pm
Allarity Therapeutics Announces Changes to Board of Directors | ALLR Stock News
GuruFocus News • 3:16pm
Jun 04, 2025
Allarity (ALLR) Partners with Indiana Biosciences for Stenoparib Research | ALLR Stock News
GuruFocus News • 7:20am
Allarity Therapeutics Announces Research Collaboration with Indiana Biosciences Research Institute to Further Advance Understanding of Stenoparib's Unique, Dual Therapeutic Mechanism of Action
Marketwired • 7:00am
Jun 02, 2025
Allarity (ALLR) Advances Phase 2 Trial for Ovarian Cancer Drug Stenoparib | ALLR Stock News
GuruFocus News • 7:50am
Allarity Therapeutics Announces First Patient Enrolled in New Phase 2 Clinical Trial Protocol of Stenoparib in Advanced Ovarian Cancer
Marketwired • 7:00am
May 12, 2025
Allarity Therapeutics Announces Participation in Pharma Partnering Summit US
Marketwired • 7:00am
May 09, 2025
Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment
Marketwired • 4:00pm
Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment | ALLR Stock News
GuruFocus News • 3:17pm
Apr 25, 2025
Allarity Therapeutics (ALLR) Unveils New Predictor for Cancer Therapy | ALLR Stock News
GuruFocus News • 7:48am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news